Art

J-GLOBAL ID：201002238572615803   Reference number：10A1150046

Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 study

用量漸増ドキソルビシンによる強化地固め療法は急性リンパ芽球性白血病の成人の予後を改善しなかった:JALSG-ALL97試験

Author (21)： JINNAI Itsuro (Ogawa Red Cross Hospital, Saitama, JPN) ,  JINNAI Itsuro (Saitama Medical Univ., Hidaka, JPN) ,  SAKURA Tohru (Maebashi Saiseikai Hospital, Maebashi, JPN) ,  TSUZUKI Motohiro (Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  MAEDA Yasuhiro (Kinki Univ. School of Medicine, Osaka-Sayama, JPN) ,  USUI Noriko (Jikei Univ. School of Medicine, Tokyo, JPN) ,  KATO Masayuki (St. Marianna Univ. School of Medicine, Kawasaki, JPN) ,  OKUMURA Hirokazu (Kanazawa Univ. Graduate School of Medical Sci., Kanazawa, JPN) ,  KYO Taiichi (Hiroshima Red Cross Hospital, Hiroshima, JPN) ,  UEDA Yasunori (Kurashiki Central Hospital, Kurashiki, JPN) ,  KISHIMOTO Yuji (Kansai Medical Univ., Hirakata, JPN) ,  YAGASAKI Fumiharu (Saitama Medical Univ., Hidaka, JPN) ,  TSUBOI Kosuke (Tokai Univ. School of Medicine, Isehara, JPN) ,  HORIIKE Shigeo (Kyoto Prefectural Univ. Medicine, Kyoto, JPN) ,  TAKEUCHI Jin (Nihon Univ. School of Medicine, Tokyo, JPN) ,  IWANAGA Masako (Nagasaki Univ. Graduate School of Biomedical Sci., Nagasaki, JPN) ,  MIYAZAKI Yasushi (Nagasaki Univ. Graduate School of Biomedical Sci., Nagasaki, JPN) ,  MIYAWAKI Shuichi (Tokyo Metropolitan Ohtsuka Hospital, Tokyo, JPN) ,  OHNISHI Kazunori (Hamamatsu Univ. School of Medicine, Hamamatsu, JPN) ,  NAOE Tomoki (Nagoya Univ. Graduate School of Medicine, Nagoya, JPN) ,  OHNO Ryuzo (Aichi Shukutoku Univ., Nagoya, JPN)
Material： International Journal of Hematology  (Int J Hematol)
Volume： 92  Issue： 3  Page： 490-502  Publication year： Oct. 2010 
JST Material Number： F0888A  ISSN： 0925-5710  CODEN： IJHEEY  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： clinical pharmacological test ,...
Semi thesaurus term： フィラデルフィア染色体陰性急性リンパ性白血病 ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=10A1150046&from=J-GLOBAL&jstjournalNo=F0888A") }}

JST classification (2)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Blood cell tumors(=neoplasms)  (GK04000M)

Substance index (1)： Doxorubicin

Reference (29)：

• DRUKER, BJ. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med. 2001, 344, 1038-1042
• YANADA, M. Recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Int J Hematol. 2009, 89, 3-13
• LARSON, RA. A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia : CALGB study 9111. Blood. 1998, 92, 1556-1564
• TAKEUCHI, J. Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia : the JALSG-ALL93 study. Leukemia. 2002, 16, 1259-1266
• KANTARJIAN, H. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer. 2004, 101, 2788-2801

Terms in the title (9)： 用量 ,  漸増 ,  ドキソルビシン ,  強化 ,  地固め療法 ,  急性リンパ芽球性白血病 ,  成人 ,  予後 ,  試験